
Wednesday, November 13, 2013 4:23:00 PM
It looks as if our long wait will continue for awhile more; but the end results seem a bit more certain now. Thanks for taking the time to post this info. It is very encouraging.
PhilB
Recent AEMD News
- Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors • Edgar (US Regulatory) • 02/14/2025 06:21:10 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2025 10:15:16 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/12/2025 09:15:12 PM
- Aethlon Medical Announces Financial Results for the Fiscal Third Quarter Ended December 31, 2024 and Provides Corporate Update • PR Newswire (US) • 02/12/2025 09:15:00 PM
- Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 12, 2025 • PR Newswire (US) • 02/05/2025 01:01:00 PM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 01/30/2025 10:26:42 PM
- Aethlon Medical Treats First Patient in Australian Hemopurifier® Cancer Trial • PR Newswire (US) • 01/29/2025 01:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2025 01:20:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2025 10:15:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2025 10:15:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/03/2025 10:15:04 PM
- Form 1-A - Offering Statement [Regulation A] • Edgar (US Regulatory) • 12/27/2024 09:51:26 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2024 01:01:08 PM
- Aethlon Medical Provides Update on the Ability of Its Hemopurifier® to Capture H5N1 Bird Flu • PR Newswire (US) • 12/20/2024 01:01:00 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 11/15/2024 09:40:55 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2024 10:15:18 PM
- Aethlon Medical Announces Financial Results for the Fiscal Second Quarter Ended September 30, 2024 and Provides Corporate Update • PR Newswire (US) • 11/13/2024 09:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2024 02:00:08 PM
- Aethlon Medical Reaches Key Milestone with Enrollment of the First Patient in (FPI) Its Hemopurifier® Cancer Trial in Australia • PR Newswire (US) • 11/11/2024 01:01:00 PM
- Aethlon Medical to Release Fiscal Second Quarter Financial Results and Host Conference Call on November 13, 2024 • PR Newswire (US) • 11/06/2024 01:01:00 PM
- Aethlon Medical to Participate in the 2024 Maxim Healthcare Virtual Summit • PR Newswire (US) • 10/08/2024 12:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2024 08:44:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/02/2024 09:00:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 09:30:06 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/01/2024 09:30:04 PM
VAYK Proposes 100 million Buyback through Private Repurchases • VAYK • Feb 28, 2025 9:00 AM
ConnectM Eliminates an Additional $1.9 Million of Debt • CNTM • Feb 27, 2025 4:01 PM
Consumer Automotive Finance, Inc. Announces Nationwide Teleconference as It Transitions to Fifty 1 Labs, Inc. • CAFI • Feb 27, 2025 9:00 AM
VPR Brands Secures Settlement Agreement With POP Vapor, Reinforcing Commitment to Intellectual Property Protection • VPRB • Feb 27, 2025 8:49 AM
Wytec Begins Sales of Its Multi-Government AI Threat Detection Sensor Technology • WYTC • Feb 27, 2025 7:05 AM
VAYK Issues Clerical Correction to Feb 18 News Regarding Shareholder Premium • VAYK • Feb 26, 2025 10:32 AM